Prostate News Archive
19-Jan-2007
Immunicon: Prostate Cancer Test Works (AP via Yahoo! Finance)
Immunicon Corp. said Thursday that its cancer test predicted the survival of prostate cancer patients on chemotherapy. The Philadelphia-area company said the late stage clinical study of its CellSearch Circulating Tumor Cell Kit found that circulating tumor cells levels measured three-to-five weeks after chemotherapy was started predict overall survival in prostate cancer patients whose disease ... Immunicon Achieves Endpoint in Its Pivotal Clinical Trial in Metastatic Androgen-Independent Prostate Cancer (RedNova)
Immunicon Corporation (NASDAQ-GM:IMMC) announced today that the Company met its primary endpoint associated with its pivotal clinical trial in metastatic androgen-independent prostate cancer. Tomato-Broccoli Combo May Protect Against Prostate Cancer (HealthCentral.com)
TUESDAY, Jan. 16 (HealthDay News) -- Broccoli and tomato -- two vegetables known to help fight cancer -- are more effective against prostate cancer if they're eaten together as part of a daily diet than if they're eaten alone, a new study with rats suggests.
Back to Prostate News Archive
